Fundraising FoxVOCxi
Arden Hills, US · Founded 2022 · 6 known investors
Find your way into VOCxi
Sign up to see every warm intro you have to VOCxi
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VOCxi team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vocxi Health develops MyBreathPrint, a noninvasive breath-analysis device that detects volatile organic compounds to screen for lung cancer and other diseases early. The system uses nanotechnology and machine learning to provide immediate diagnostic results without needles, radiation, or surgery.
Founders & leadership
Board
Investors · 6
How we know: Alliance of Angels's portfolio page · Not right? Tell us
How we know: Great North Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: GROOVE CAPITAL's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Samsung Next's portfolio page · Not right? Tell us
How we know: Taiwan Global Angels's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4.7M disclosed across 2 rounds · 2022–2024
▶$800KraisedJul 2024 · 8 investors · Other Health CareRule 506(b)
- Morgan EvansDirector
- Greg SherwoodExecutive Officer, Director, Promoter
- Randy SchiestlExecutive Officer, Director, Promoter
- Yung-Ping YehExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $800K
- Minimum investment
- $25K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$3.9MraisedSep 2023 · 13 investors · Other Health CareRule 506(b)
- Randy SchiestlExecutive Officer, Director
- Greg SherwoodExecutive Officer, Director
- Morgan EvansDirector
- Yung-Ping YehExecutive Officer, Director
- Offering amount
- $6.5M
- Amount sold
- $3.9M
- Minimum investment
- $25K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does VOCxi do?
- Vocxi Health develops MyBreathPrint, a noninvasive breath-analysis device that detects volatile organic compounds to screen for lung cancer and other diseases early. The system uses nanotechnology and machine learning to provide immediate diagnostic results without needles, radiation, or surgery.
- Who are VOCxi's investors?
- VOCxi's investors include Alliance of Angels, Great North Ventures, GROOVE CAPITAL, Samsung Next, Taiwan Global Angels, Kitchen Fund.
- How much funding has VOCxi raised?
- VOCxi has disclosed $4.7M raised across 2 rounds.
- Where is VOCxi headquartered?
- VOCxi is headquartered in Arden Hills, US.